Clinical trials
Cancer Patients clinical trials
Below are recruiting cancer patients clinical trials, each written for real people, not researchers. We’re tracking 3,535 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06085716RecruitingPhase 2/Phase 3
Combination therapy for advanced cancer fatigue
This study tests a combination of treatments (including education and counseling) to see if they can reduce severe fatigue in people with advanced cancer. It's for patients who are seen at MD Anderson Cancer Center in Texas and can attend sessions in person or online.
Houston, TexasAges 18 years+ - NCT07088536Recruiting
Returning to work after urology surgery
This study looks at how urology surgeries, like removing a kidney or treating kidney stones, affect patients' ability to return to work. It will help doctors understand the challenges patients face when going back to their jobs.
Krakow, MalopolskaAges 18 years+ - NCT05401175Recruiting
Self-transfusion to protect bone marrow during cervical cancer treatment
This trial studies whether returning your own blood stem cells back to you (from a processed blood sample) can help protect your bone marrow while you receive chemotherapy and/or radiation for cervical cancer. It may help reduce treatment-related damage to the bone marrow that produces blood cells.
Chongqing, Chongqing MunicipalityAges 18–60 - NCT06332274RecruitingPhase 3
Tislelizumab for cancer patients with minimal residual disease
This trial is for people who have completed standard cancer treatments (like surgery, chemo or radiation) and have no visible cancer on scans, but may still have very small amounts of cancer DNA in their blood. The study tests whether the drug tislelizumab can help prevent the cancer from coming back.
Villejuif, Val De MarneAges 18 years+ - NCT07299409RecruitingPhase 2
Study of sacituzumab govitecan for advanced triple-negative breast cancer
This study tests a drug called sacituzumab govitecan (a type of antibody-drug conjugate that targets cancer cells) as the first treatment for people with advanced triple-negative breast cancer that has not been treated before. The goal is to see if it can help shrink or control the cancer.
Vancouver, British ColumbiaAges 18 years+ - NCT06522828RecruitingPhase 2
Study of SSGJ-707 for advanced gynecologic cancers
This trial tests a new drug called SSGJ-707 for people with advanced endometrial cancer or ovarian cancer that no longer responds to platinum-based chemotherapy. The goal is to see if it can help shrink or slow down the cancer.
ChongqingAges 18–75 - NCT07549477Recruiting
Heart imaging study for cancer patients with catheter clots
This study uses a special heart imaging test (cardiac MRI) to look for and understand blood clots that may form around central catheters (tubes placed in veins) in people with cancer. The imaging helps doctors see if clots are present and what type they are, which could improve how they care for cancer patients.
Basking Ridge, New JerseyAges 18 years+ - NCT06481813Recruiting
Lung Cancer Biobank Study for Newly Diagnosed Patients
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
AngersAges 18 years+ - NCT06401174Enrolling by invitation
Patient navigation for colorectal cancer screening
This study tests a patient navigation program to help people who are due for colorectal cancer screening get the test they need. It connects you with a guide to make scheduling and completing screening easier.
Washington D.C., District of ColumbiaAges 45–75 - NCT07634978Recruiting
AI Chatbot Health Education for Thyroid Cancer Surgery
This study tests whether an AI chatbot can help thyroid cancer patients understand their surgery and recovery better. You would use the chatbot before and after your scheduled thyroid surgery to answer questions and learn about what to expect.
Tianjin, Tianjin MunicipalityAges 18–60 - NCT06263088Recruiting
Equity in GI Cancer Care Study
This trial is looking for Black patients newly diagnosed with any stage of gastrointestinal cancer to help improve cancer care and make sure research includes everyone. By joining, you help doctors learn how to better support patients like you.
Cleveland, OhioAges 18 years+ - NCT07302451RecruitingPhase 2
Recovering erectile function after prostate cancer treatment
This trial tests a program to help men recover erectile function after prostate cancer treatment. It is for men with a specific type of prostate cancer that hasn't spread and who still have some erectile function.
NaplesAges 18 years+ - NCT03731442RecruitingPhase 3
Radiation plus chemotherapy for esophageal cancer that came back
This Phase 3 trial studies giving combined chemotherapy and radiation to treat esophageal cancer that has returned after earlier surgery and/or prior treatments. It may help control the cancer in the area where it comes back, especially when the surgical margins were not fully clear or the cancer is outside the original radiation field.
Beijing, Beijing MunicipalityAges 16–70 - NCT04086290RecruitingPhase 1/Phase 2
Surgery plus targeted radiation for prostate cancer spread
This study looks at whether combining prostate surgery with a highly focused radiation treatment (SBRT) can control prostate cancer that has spread to a limited number of bones. It may help patients by treating the main tumor and the specific metastatic spots in a controlled way.
HerlevAges 18 years+ - NCT05884632Recruiting
Personalized daily radiation for prostate cancer after surgery
This trial studies a “daily adaptive” way of planning and delivering radiation after prostate surgery to treat prostate cancer that is coming back locally. It may help target the tumor more precisely while limiting radiation to healthy tissue.
Negrar, VeronaAges 18–80 - NCT05797467RecruitingPhase 3
After-surgery chemo plus targeted therapy for colon cancer
This Phase 3 trial studies whether adding targeted therapy to standard chemotherapy after surgery helps people with stage T3-4, N2 colon cancer live longer or have fewer cancer returns. You would be assigned to receive chemotherapy with targeted therapy or chemotherapy alone, based on the study plan.
Guangzhou, GuangdongAges 18–75 - NCT06073418Recruiting
Diet, nutrition, and physical activity in early breast cancer
This study looks at the eating habits, nutrition knowledge, and physical activity of women with early-stage breast cancer. It aims to understand how these factors relate to your health and recovery after surgery.
Aviano, PordononeAges 18 years+ - NCT06169072RecruitingPhase 2
Finding lymph nodes with a tiny dose of magnetic tracer in breast cancer
This trial is testing whether a very small amount of a magnetic tracer called Magtrace can help find lymph nodes that need to be checked for cancer spread during breast cancer surgery.
GothenburgAges 18 years+ - NCT06259513Recruiting
Skipping armpit surgery for breast cancer patients
This trial tests whether it's safe to skip armpit surgery in older women with small, low-risk breast cancers. If you qualify, you would have a mastectomy without removing lymph nodes from your armpit.
SingaporeAges 21–80 - NCT05068531Recruiting
Detecting early treatment failure in stage IV colon cancer
This study looks for early signs that treatment is not working in people with stage IV colon or rectal cancer that has spread only to the liver. It may help doctors adjust care sooner by using regular blood, stool, and tissue samples around liver procedures.
Montreal, QuebecAges 18 years+ - NCT06404697RecruitingPhase 2
Extra radiation to lymph nodes above collarbone for high-risk breast cancer
This trial tests giving a focused, higher dose of radiation to the lymph nodes above the collarbone after breast cancer treatment. It is for patients whose cancer did not fully disappear from those nodes after pre-surgery chemotherapy, to see if extra radiation can help prevent recurrence.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05739968Recruiting
Active living program for early bladder cancer patients with their own bladder
This trial tests whether a structured “active-living” program (helping you be more active in daily life) improves outcomes for people newly diagnosed with operable early bladder cancer. It may help with overall health and quality of life while you receive standard bladder cancer care without removing your bladder.
TaipeiAges Any age - NCT07839702Recruiting
Pre-surgery exercise and nutrition program for stomach cancer
This trial tests a home-based program of exercises and nutritional drinks before stomach cancer surgery. It aims to help patients recover faster and feel stronger after their operation.
SingaporeAges 22–99 - NCT06314646Recruiting
Comparing two ways to reconnect the intestine after rectal cancer surgery
This study compares two ways of reconnecting the intestine after rectal cancer surgery. It looks at a newer method called TTSS against the standard double-stapled technique.
Rozzano, MIAges 18 years+
Hear when a new Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer patients?
- Yes. Clin2 currently lists 3,535 recruiting cancer patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.